Zeo ScientifiX, Inc. (ZEOX)

Market Cap	13.82M
Revenue (ttm)	4.93M
Net Income (ttm)	-5.15M
Shares Out	6.58M
EPS (ttm)	-0.78
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,100
Open	2.100
Previous Close	2.000
Day's Range	2.100 - 2.150
52-Week Range	0.800 - 3.800
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 13, 2024

About Zeo ScientifiX

Zeo ScientifiX, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. Its lead product candidate is Zofin, an acellular biologic therapeutic derived from perinatal sources, which is in Phase I/II clinical trial to treat COVID-19, chronic obstructive pulmonary disease, and knee osteoarthritis. The company also provides Patient Pure X, an autologous blood-derived biologic technology, that is placed in the body for exosomes the ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2011
• Employees: 23
• Stock Exchange: OTCMKTS
• Ticker Symbol: ZEOX

Financial Performance

In 2023, Zeo ScientifiX's revenue was $4.56 million, a decrease of -29.78% compared to the previous year's $6.49 million. Losses were -$6.99 million, -21.47% less than in 2022.